Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention

Clinical trial NCT02114528 · TERMINATED

Trial details

NCT number: NCT02114528
Sponsor: Ottawa Heart Institute Research Corporation
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Ventricular Tachycardia Ventricular Arrhythmia

Start date: 2014-10-01
Primary completion: 2015-11-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.